Insulet PODD EPS (Basic)
EPS (Basic) at other companies
Other financials
Where this comes from
Reported directly by Insulet in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.
The official record: Insulet’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Insulet's eps (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Insulet's EPS (basic)?
- Insulet (PODD) reported EPS (basic) of $1.30 in Q1 2026.
- How has Insulet's EPS (basic) changed year-over-year?
- Insulet's EPS (basic) increased by 160.0% year-over-year, from $0.50 to $1.30.
- What is the long-term trend for Insulet's EPS (basic)?
- Over 4 years (2021 to 2025), Insulet's EPS (basic) has grown at a 95.4% compound annual growth rate (CAGR), from $0.24 to $3.50.
- What does EPS (basic) mean?
- The portion of profit allocated to each outstanding share of common stock.
- How do you interpret EPS (basic)?
- An increasing trend suggests growing profitability per share, which is a key driver of shareholder value and stock price performance.
- How does EPS (basic) compare across companies?
- Standard metric used by analysts to compare valuation multiples across the medical technology industry.